A citation-based method for searching scientific literature

Christopher T Johansen, Sekar Kathiresan, Robert A Hegele. J Lipid Res 2011
Times Cited: 178







List of co-cited articles
845 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.
Robert A Hegele, Henry N Ginsberg, M John Chapman, Børge G Nordestgaard, Jan Albert Kuivenhoven, Maurizio Averna, Jan Borén, Eric Bruckert, Alberico L Catapano, Olivier S Descamps,[...]. Lancet Diabetes Endocrinol 2014
297
28

Biological, clinical and population relevance of 95 loci for blood lipids.
Tanya M Teslovich, Kiran Musunuru, Albert V Smith, Andrew C Edmondson, Ioannis M Stylianou, Masahiro Koseki, James P Pirruccello, Samuli Ripatti, Daniel I Chasman, Cristen J Willer,[...]. Nature 2010
27

Discovery and refinement of loci associated with lipid levels.
Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen, Martin L Buchkovich, Samia Mora,[...]. Nat Genet 2013
22

Chylomicronaemia--current diagnosis and future therapies.
Amanda J Brahm, Robert A Hegele. Nat Rev Endocrinol 2015
159
21

Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
R P Surendran, M E Visser, S Heemelaar, J Wang, J Peter, J C Defesche, J A Kuivenhoven, M Hosseini, M Péterfy, J J P Kastelein,[...]. J Intern Med 2012
149
20

Common variants at 30 loci contribute to polygenic dyslipidemia.
Sekar Kathiresan, Cristen J Willer, Gina M Peloso, Serkalem Demissie, Kiran Musunuru, Eric E Schadt, Lee Kaplan, Derrick Bennett, Yun Li, Toshiko Tanaka,[...]. Nat Genet 2009
997
19

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
Jacy Crosby, Gina M Peloso, Paul L Auer, David R Crosslin, Nathan O Stitziel, Leslie A Lange, Yingchang Lu, Zheng-zheng Tang, He Zhang, George Hindy,[...]. N Engl J Med 2014
627
18

An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia.
Christopher T Johansen, Jian Wang, Matthew B Lanktree, Adam D McIntyre, Matthew R Ban, Rebecca A Martins, Brooke A Kennedy, Reina G Hassell, Maartje E Visser, Stephen M Schwartz,[...]. Arterioscler Thromb Vasc Biol 2011
63
26

Hypertriglyceridemia.
Amanda Brahm, Robert A Hegele. Nutrients 2013
65
24

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.
Christopher T Johansen, Jian Wang, Matthew B Lanktree, Henian Cao, Adam D McIntyre, Matthew R Ban, Rebecca A Martins, Brooke A Kennedy, Reina G Hassell, Maartje E Visser,[...]. Nat Genet 2010
333
16

Common variants associated with plasma triglycerides and risk for coronary artery disease.
Ron Do, Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Chi Gao, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen,[...]. Nat Genet 2013
532
15

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Børge G Nordestgaard, Marianne Benn, Peter Schnohr, Anne Tybjaerg-Hansen. JAMA 2007
14

Hypertriglyceridemia: its etiology, effects and treatment.
George Yuan, Khalid Z Al-Shali, Robert A Hegele. CMAJ 2007
305
13

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
Nadeem Sarwar, Manjinder S Sandhu, Sally L Ricketts, Adam S Butterworth, Emanuele Di Angelantonio, S Matthijs Boekholdt, Willem Ouwehand, Hugh Watkins, Nilesh J Samani, Danish Saleheen,[...]. Lancet 2010
460
13

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.
Anders Berg Jørgensen, Ruth Frikke-Schmidt, Børge G Nordestgaard, Anne Tybjærg-Hansen. N Engl J Med 2014
535
13

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.
Michael Miller, Neil J Stone, Christie Ballantyne, Vera Bittner, Michael H Criqui, Henry N Ginsberg, Anne Carol Goldberg, William James Howard, Marc S Jacobson, Penny M Kris-Etherton,[...]. Circulation 2011
13

Allelic and phenotypic spectrum of plasma triglycerides.
Christopher T Johansen, Robert A Hegele. Biochim Biophys Acta 2012
38
31

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.
Toni I Pollin, Coleen M Damcott, Haiqing Shen, Sandra H Ott, John Shelton, Richard B Horenstein, Wendy Post, John C McLenithan, Lawrence F Bielak, Patricia A Peyser,[...]. Science 2008
440
12

Triglycerides and cardiovascular disease.
Børge G Nordestgaard, Anette Varbo. Lancet 2014
586
12

Targeting APOC3 in the familial chylomicronemia syndrome.
Daniel Gaudet, Diane Brisson, Karine Tremblay, Veronica J Alexander, Walter Singleton, Steven G Hughes, Richard S Geary, Brenda F Baker, Mark J Graham, Rosanne M Crooke,[...]. N Engl J Med 2014
255
11

Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
Lars Berglund, John D Brunzell, Anne C Goldberg, Ira J Goldberg, Frank Sacks, Mohammad Hassan Murad, Anton F H Stalenhoef. J Clin Endocrinol Metab 2012
390
11

Hypertriglyceridemia in the genomic era: a new paradigm.
Gary F Lewis, Changting Xiao, Robert A Hegele. Endocr Rev 2015
77
14

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
Daniel Gaudet, Veronica J Alexander, Brenda F Baker, Diane Brisson, Karine Tremblay, Walter Singleton, Richard S Geary, Steven G Hughes, Nicholas J Viney, Mark J Graham,[...]. N Engl J Med 2015
304
11

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.
Kiran Musunuru, James P Pirruccello, Ron Do, Gina M Peloso, Candace Guiducci, Carrie Sougnez, Kiran V Garimella, Sheila Fisher, Justin Abreu, Andrew J Barry,[...]. N Engl J Med 2010
409
10

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
L A Pennacchio, M Olivier, J A Hubacek, J C Cohen, D R Cox, J C Fruchart, R M Krauss, E M Rubin. Science 2001
697
10


Severe hypertriglyceridemia is primarily polygenic.
Jacqueline S Dron, Jian Wang, Henian Cao, Adam D McIntyre, Michael A Iacocca, Jyler R Menard, Irina Movsesyan, Mary J Malloy, Clive R Pullinger, John P Kane,[...]. J Clin Lipidol 2019
65
15

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.
M John Chapman, Henry N Ginsberg, Pierre Amarenco, Felicita Andreotti, Jan Borén, Alberico L Catapano, Olivier S Descamps, Edward Fisher, Petri T Kovanen, Jan Albert Kuivenhoven,[...]. Eur Heart J 2011
728
9

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.
Anne P Beigneux, Brandon S J Davies, Peter Gin, Michael M Weinstein, Emily Farber, Xin Qiao, Franklin Peale, Stuart Bunting, Rosemary L Walzem, Jinny S Wong,[...]. Cell Metab 2007
313
9

Genetic bases of hypertriglyceridemic phenotypes.
Christopher T Johansen, Robert A Hegele. Curr Opin Lipidol 2011
78
11

Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia.
Christopher T Johansen, Jian Wang, Adam D McIntyre, Rebecca A Martins, Matthew R Ban, Matthew B Lanktree, Murray W Huff, Miklós Péterfy, Margarete Mehrabian, Aldons J Lusis,[...]. Circ Cardiovasc Genet 2012
65
13

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
Len A Pennacchio, Michael Olivier, Jaroslav A Hubacek, Ronald M Krauss, Edward M Rubin, Jonathan C Cohen. Hum Mol Genet 2002
320
9


Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Joseph L Witztum, Daniel Gaudet, Steven D Freedman, Veronica J Alexander, Andres Digenio, Karren R Williams, Qingqing Yang, Steven G Hughes, Richard S Geary, Marcello Arca,[...]. N Engl J Med 2019
131
9


Major lipids, apolipoproteins, and risk of vascular disease.
Emanuele Di Angelantonio, Nadeem Sarwar, Philip Perry, Stephen Kaptoge, Kausik K Ray, Alexander Thompson, Angela M Wood, Sarah Lewington, Naveed Sattar, Chris J Packard,[...]. JAMA 2009
8

GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.
Brandon S J Davies, Anne P Beigneux, Richard H Barnes, Yiping Tu, Peter Gin, Michael M Weinstein, Chika Nobumori, Rakel Nyrén, Ira Goldberg, Gunilla Olivecrona,[...]. Cell Metab 2010
233
8

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones,[...]. J Am Coll Cardiol 2014
8


Issues in hypertriglyceridemic pancreatitis: an update.
John Scherer, Vijay P Singh, C S Pitchumoni, Dhiraj Yadav. J Clin Gastroenterol 2014
192
8

Newly identified loci that influence lipid concentrations and risk of coronary artery disease.
Cristen J Willer, Serena Sanna, Anne U Jackson, Angelo Scuteri, Lori L Bonnycastle, Robert Clarke, Simon C Heath, Nicholas J Timpson, Samer S Najjar, Heather M Stringham,[...]. Nat Genet 2008
8

Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia.
Martine Paquette, Sophie Bernard, Robert A Hegele, Alexis Baass. Atherosclerosis 2019
26
30

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Anders Berg Jørgensen, Ruth Frikke-Schmidt, Anders Sode West, Peer Grande, Børge G Nordestgaard, Anne Tybjærg-Hansen. Eur Heart J 2013
225
7

Physiological regulation of lipoprotein lipase.
Sander Kersten. Biochim Biophys Acta 2014
264
7

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
Sandeep Bansal, Julie E Buring, Nader Rifai, Samia Mora, Frank M Sacks, Paul M Ridker. JAMA 2007
7

The complex genetic basis of plasma triglycerides.
Christopher T Johansen, Robert A Hegele. Curr Atheroscler Rep 2012
31
22

Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.
Mark J Graham, Richard G Lee, Thomas A Bell, Wuxia Fu, Adam E Mullick, Veronica J Alexander, Walter Singleton, Nick Viney, Richard Geary, John Su,[...]. Circ Res 2013
227
7

Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.
Stefano Romeo, Wu Yin, Julia Kozlitina, Len A Pennacchio, Eric Boerwinkle, Helen H Hobbs, Jonathan C Cohen. J Clin Invest 2009
271
7

Deletion of GPIHBP1 causing severe chylomicronemia.
Jonathan J Rios, Savitha Shastry, Juan Jasso, Natalie Hauser, Abhimanyu Garg, André Bensadoun, Jonathan C Cohen, Helen H Hobbs. J Inherit Metab Dis 2012
67
10

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias.
Christopher T Johansen, Joseph B Dubé, Melissa N Loyzer, Austin MacDonald, David E Carter, Adam D McIntyre, Henian Cao, Jian Wang, John F Robinson, Robert A Hegele. J Lipid Res 2014
89
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.